ArticleJAMA network open2026
Financial Toxicity Among Disaggregated Asian American Cancer Survivors.
Article in JAMA network open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Importance: Panethnic categorization of Asian American individuals masks sociodemographic diversity. Whether this aggregation obscures heterogeneity in cancer-related financial toxicity remains unknown due to a lack of disaggregated data. Objective: To evaluate associations between disaggregated Asian American identity and financial toxicity among cancer survivors compared with non-Hispanic White survivors. Design, Setting, and Participants: This cross-sectional study analyzed National Institutes of Health All of Us Research Program data. Participants were Asian American and non-Hispanic White adults with an electronic health record-confirmed malignant neoplasm diagnosed before completing financial toxicity surveys. Surveys were completed between June 2018 and December 2024; analyses concluded July 2026. Exposures: Self-reported Asian and non-Hispanic White race; self-reported Chinese, Filipino, Indian or Pakistani, Japanese, Korean, and Vietnamese ethnicity. Main Outcomes and Measures: Three financial toxicity domains were assessed: cost-related nonadherence, foregone medical care, and financial worry. Adjusted odds ratios (AORs) were estimated using multivariable logistic regression adjusting for clinical covariates, with sequential adjustment for socioeconomic factors and nativity. Results: The cohort included 55 511 survivors (median [IQR] age, 66.0 [56.0-73.0] years): 54 230 (97.7%) non-Hispanic White and 1281 (2.3%) Asian American individuals. Overall, 27 316 (49.2%) experienced at least 1 financial toxicity domain. In the clinical baseline model, Chinese survivors had lower odds of cost-related nonadherence than non-Hispanic White survivors (AOR, 0.68; 95% CI, 0.53-0.88). Vietnamese (AOR, 2.15; 95% CI, 1.30-3.56), Filipino (AOR, 1.58; 95% CI, 1.22-2.07), and Japanese (AOR, 1.44; 95% CI, 1.10-1.89) survivors had higher odds of financial worry than non-Hispanic White survivors. In aggregate, Asian American identity was associated with lower cost-related nonadherence odds (AOR, 0.79; 95% CI, 0.69-0.92) and higher financial worry odds (AOR, 1.31; 95% CI, 1.16-1.47). Worry associations attenuated after nativity adjustment. Conclusions and Relevance: In this cross-sectional study, disaggregation revealed heterogeneity in financial toxicity across Asian American subgroups, which was obscured by panethnic classification. Elevated financial worry may reflect immigration factors and US wealth accumulation rather than income alone. Disaggregated data are needed to effectively target financial navigation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.